Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.

Nina KimerJulie S PedersenJuliette TavenierJeffrey E ChristensenTroels M BuskLise HobolthAleksander KragWaleed Abu Al-SoudMartin S MortensenSøren J SørensenSøren MøllerFlemming Bendtsennull null

Published in: Journal of gastroenterology and hepatology (2018)

Four weeks of treatment with rifaximin had no impact on the inflammatory state and only minor effects on BT and intestinal bacterial composition in stable, decompensated cirrhosis (NCT01769040).

Keyphrases

oxidative stress
heart failure
ejection fraction
hepatitis b virus
combination therapy
preterm birth